OncoNano Medicine, Inc.   Report issue

For profit Phase 2
Founded: Dallas TX United States (2014)

Organization Overview

First Clinical Trial
2019
NCT03735680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

OncoNano Medicine, Inc.